These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 10262828)

  • 1. Implementing and maintaining a viable formulary.
    Kelly WN; Bender FH
    Hosp Formul; 1983 Oct; 18(10):976-8, 981-2, 987. PubMed ID: 10262828
    [No Abstract]   [Full Text] [Related]  

  • 2. Survey of formulary system policies and procedures.
    Rascati KL
    Am J Hosp Pharm; 1992 Jan; 49(1):100-3. PubMed ID: 1570847
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Guidelines on the operation of the pharmacy and therapeutics committee and formulary.
    Linkewich JA; Prevoznik SJ
    Hosp Pharm; 1979 Jan; 14(1):7-10, 13, 16-9 passim. PubMed ID: 10240149
    [No Abstract]   [Full Text] [Related]  

  • 4. ASHP guidelines on formulary system management.
    Am J Hosp Pharm; 1992 Mar; 49(3):648-52. PubMed ID: 1598948
    [No Abstract]   [Full Text] [Related]  

  • 5. Key inventory to formulary to cut drug costs.
    Schmieding JL; Sita MJ
    Hospitals; 1980 Sep; 54(17):78-81. PubMed ID: 7399457
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A survey of selective administration procedures in formulary maintenance.
    Quigley MA; Brown WM
    Hosp Pharm; 1981 Jul; 15(7):371-4, 378-80. PubMed ID: 10252001
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Developing an effective P & T Committee, Part 2.
    Abramowitz PW; Godwin HN; Latiolais CJ; McDougal TR; Miller WA; Ravin RL
    Hosp Formul; 1985 Oct; 20(10):1071-2, 1078-81, 1086 passim. PubMed ID: 10273830
    [TBL] [Abstract][Full Text] [Related]  

  • 8. P&T committee: an approach to formulary consideration of antimicrobial agents--introduction.
    Andriole VT; Ryan JL
    Hosp Formul; 1981 Jun; 16(6):619, 623. PubMed ID: 10251442
    [No Abstract]   [Full Text] [Related]  

  • 9. How to develop a proactive formulary system.
    Crane VS; Gonzalez ER; Hull BL
    Hosp Formul; 1994 Oct; 29(10):700-2, 704-8, 710. PubMed ID: 10137847
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Formulary status of intravenous immunoglobulins in selected hospitals.
    Hatton RC; Doering PL; Fakhoury M; Williams RB
    Am J Hosp Pharm; 1988 Nov; 45(11):2377-9. PubMed ID: 3228096
    [No Abstract]   [Full Text] [Related]  

  • 11. The foremost problems associated with formulary management.
    Davis NM
    Hosp Pharm; 1983 Mar; 18(3):131, 134-5. PubMed ID: 10260204
    [No Abstract]   [Full Text] [Related]  

  • 12. P & T Committee interview: communication and education contribute to an effective formulary system.
    Hinthorn D; Godwin H
    Hosp Formul; 1989 May; 24(5):281-4, 286-7. PubMed ID: 10292977
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Communicating P & T guidelines: how one committee meets the challenge.
    Dreyfus R; Bender F
    Hosp Formul; 1987 Jul; 22(7):651-4, 657. PubMed ID: 10282681
    [TBL] [Abstract][Full Text] [Related]  

  • 14. What should your formulary look like?
    Lanser EG
    Healthc Exec; 2002; 17(1):52. PubMed ID: 11822245
    [No Abstract]   [Full Text] [Related]  

  • 15. Point: the formulary system and the emperor's new clothes.
    Green JA
    Am J Hosp Pharm; 1986 Nov; 43(11):2830-4. PubMed ID: 3799622
    [No Abstract]   [Full Text] [Related]  

  • 16. Improving pharmacy and therapeutics committee operations.
    Cohen MR; Klapp D; Miller KB; Shaffer VL; Slotfeldt M; Miller DE
    Am J Hosp Pharm; 1984 Sep; 41(9):1767-77. PubMed ID: 6496511
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Counterpoint: let's expand the formulary system and renew its vigor.
    Abramowitz PW; Fletcher CV
    Am J Hosp Pharm; 1986 Nov; 43(11):2834-8. PubMed ID: 3799623
    [No Abstract]   [Full Text] [Related]  

  • 18. An inside look at the UCLA P&T committee: how does it influence prescribing practices?
    Conolly ME
    Hosp Formul; 1986 Feb; 21(2):214-7. PubMed ID: 10275576
    [TBL] [Abstract][Full Text] [Related]  

  • 19. P & T Committee perspectives: maintaining a successful formulary system in a private community hospital.
    Benner EJ; Mykita L; Brown K
    Hosp Formul; 1990 Apr; 25(4):423-6, 428, 430. PubMed ID: 10104233
    [TBL] [Abstract][Full Text] [Related]  

  • 20. How to crack the $2 billion hospital market for pharmaceuticals.
    Zellmer WA
    Med Mark Media; 1981 May; 16(5):16, 24. PubMed ID: 10251527
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 16.